Evaluation of multi-dimensional outcomes of chronic diseases: a clinical example from China

Arch Gerontol Geriatr. 2011 May-Jun;52(3):e106-9. doi: 10.1016/j.archger.2010.08.005. Epub 2010 Oct 30.

Abstract

The purpose of this study is to provide the evidence of individualized/personalized care by evaluating multi-dimensional outcomes of chronic diseases in the elderly. We used primary osteoporosis as an example, to evaluate the outcomes of three treatments (calcium combined vitamin D=Ca+vit.D; estrogen and disphosphonates) at the same time with biological dimension (bone-mineral density=BMD) and socio-psychological dimension (health-related quality of life=HR-QOL), using the medical outcomes study short-form 36-item health survey (SF-36) and cost dimension (drug cost). Using BMD as the outcome index, disphosphonate was the most effective treatment, in terms of HR-QOL, estrogen was the most effective while Ca+vit.D was the cheapest treatment, namely, different dimensional outcomes with different results. Outcome evaluation of chronic diseases in the elderly needs to combine psychological and socio-economic parameters together with the physiological measurement, to encourage a transition from "the disease-centered" to "the patient-centered" perspective as well as achieve sustainable and coordinated development of health and socio-economic resources.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Calcium / therapeutic use*
  • China / epidemiology
  • Chronic Disease
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Osteoporosis / drug therapy*
  • Osteoporosis / epidemiology*
  • Postural Balance
  • Treatment Outcome
  • Vitamin D / therapeutic use*

Substances

  • Vitamin D
  • Calcium